Scarica l'app Stockscreener
31.59
2.83%
0.87
Pre-mercato:
31.79
0.20
+0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$30.72
Aprire:
$31.11
Volume 24 ore:
339.24K
Relative Volume:
1.32
Capitalizzazione di mercato:
$1.32B
Reddito:
$384.90M
Utile/perdita netta:
$-851.00K
Rapporto P/E:
-1,579.50
EPS:
-0.02
Flusso di cassa netto:
$12.83M
1 W Prestazione:
+6.44%
1M Prestazione:
+10.92%
6M Prestazione:
+16.05%
1 anno Prestazione:
+73.19%
Intervallo 1D:
$30.22
$31.75
Intervallo di 1 settimana:
$29.81
$32.33
Portata 52W:
$16.48
$32.33
Artivion Inc Stock (AORT) Company Profile
Nome
Artivion Inc
Settore
Industria
Telefono
(770) 419-3355
Indirizzo
1655 ROBERTS BOULEVARD N W, KENNESAW
Confronta AORT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
31.59 | 1.32B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-27 | Reiterato | Lake Street | Buy |
| 2022-08-08 | Iniziato | Lake Street | Buy |
| 2022-03-03 | Iniziato | Stifel | Buy |
Artivion Inc Borsa (AORT) Ultime notizie
Artivion, Inc. (NYSE:AORT) Holdings Raised by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Is Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - MSN
Artivion (NYSE:AORT) Hits New 1-Year HighTime to Buy? - MarketBeat
CryoLife Stock Soars to 52-Week High, Hits $30.62 - Investing.com
GAMMA Investing LLC Purchases 497 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Why Investors Shouldn't Be Surprised By Artivion, Inc.'s (NYSE:AORT) P/S - Simply Wall St
New Strong Buy Stocks for January 7th - MSN
Artivion, Inc. (NYSE:AORT) Shares Sold by Principal Financial Group Inc. - Defense World
Franklin Resources Inc. Boosts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Geode Capital Management LLC Has $23.46 Million Stock Position in Artivion, Inc. (NYSE:AORT) - Defense World
Jane Street Group LLC Has $1.63 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Barclays PLC Purchases 54,996 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Barclays PLC Has $1.89 Million Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Jane Street Group LLC Purchases 24,945 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion: Current Valuation Seems Stretched (NYSE:AORT) - Seeking Alpha
Lord Abbett & CO. LLC Invests $5.80 Million in Artivion, Inc. (NYSE:AORT) - MarketBeat
The Manufacturers Life Insurance Company Has $522,000 Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Fmr LLC Has $3.07 Million Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Fmr LLC Buys 25,176 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Tidal Investments LLC Has $4.18 Million Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Wellington Management Group LLP Boosts Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
BNP Paribas Financial Markets Boosts Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion (NYSE:AORT) Earns “Market Outperform” Rating from JMP Securities - Defense World
Artivion says cybersecurity incident has disrupted order, shipping processes - MedTech Dive
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - Kilgore News Herald
In-Depth Examination Of 6 Analyst Recommendations For Artivion - Benzinga
Ransomware disrupts Artivion’s shipping processes - SC Media
Artivion's chief accounting officer Amy Horton sells shares for $128,398 By Investing.com - Investing.com South Africa
Artivion, Inc. Grants FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - Marketscreener.com
Artivion’s (AORT) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World
Artivion Cyberattack: Systems Offline, Operations Continue - The Cyber Express
Artivion reports cybersecurity incident, expects no material impact By Investing.com - Investing.com Canada
Artivion Inc. Discloses November 2024 Cyberattack, Raising Concerns of Possible Data Breach - JD Supra
Artivion's chief accounting officer Amy Horton sells shares for $128,398 - Investing.com
US medical device giant Artivion says hackers stole files during cybersecurity incident - MSN
Medical device company says shipping processes disrupted by ransomware attack - The Record from Recorded Future News
Artivion reports cybersecurity incident, expects no material impact - Investing.com
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - PR Newswire
Artivion Restoring Systems After Cyberattack - MarketWatch
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 125,668 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
FDA grants exemption for new aortic dissection device - Investing.com
Artivion to Participate in Upcoming Investor Conferences - The Eastern Progress Online
Centiva Capital LP Takes Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Walleye Capital LLC Takes Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion Inc Azioni (AORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):